CureVac N.V (CVAC) Social Stream
CUREVAC NV (CVAC) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CVAC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-19 | 3 | $65 | $41 | $53 | $3.62 | 1364.09% |
| 2022-01-05 | 4 | $55 | $41 | $48 | $3.62 | 1225.97% |
| 2022-01-18 | 4 | $55 | $41 | $49.333 | $3.62 | 1262.79% |
| 2022-04-11 | 4 | $52 | $20 | $37.666 | $3.62 | 940.5% |
| 2022-05-09 | 3 | $52 | $17 | $29.666 | $3.62 | 719.5% |
| 2022-05-27 | 3 | $52 | $17 | $29.333 | $3.62 | 710.3% |
| 2022-08-13 | 3 | $52 | $15 | $28.666 | $3.62 | 691.88% |
| 2022-08-19 | 3 | $52 | $15 | $28.333 | $3.62 | 682.68% |
| 2022-09-17 | 3 | $52 | $13 | $27.666 | $3.62 | 664.25% |
| 2022-11-17 | 3 | $34.001 | $13 | $21.667 | $3.62 | 498.54% |
| 2022-11-18 | 3 | $34.001 | $10 | $19 | $3.62 | 424.86% |
| 2023-01-06 | 3 | $34.001 | $9 | $17.667 | $3.62 | 388.04% |
| 2023-04-25 | 3 | $34.001 | $10 | $21.667 | $3.62 | 498.54% |
| 2023-05-31 | 3 | $24 | $10 | $18.333 | $3.62 | 406.44% |
| 2023-08-17 | 4 | $24 | $10 | $17 | $3.62 | 369.61% |
| 2023-11-15 | 4 | $24 | $8 | $16.25 | $3.62 | 348.9% |
| 2023-12-19 | 5 | $24 | $6.4 | $15.85 | $3.62 | 337.85% |
The Trend in the Analyst Price Target
Over the past 13 months, CVAC's average price target has gone down $1.82.
CVAC reports an average of 147.8% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-27 | 3 | 34.001 | 10.0 | 21.667 | 11.39 | 90.23% |
| 2023-05-05 | 3 | 24.000 | 10.0 | 18.333 | 8.24 | 122.49% |
| 2023-05-31 | 3 | 24.000 | 10.0 | 18.333 | 9.65 | 89.98% |
| 2023-06-08 | 4 | 24.000 | 10.0 | 17.000 | 10.50 | 61.9% |
| 2023-12-19 | 5 | 24.000 | 6.4 | 15.850 | 4.10 | 286.59% |
CVAC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 3 | 0 | 1 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 40 months, CVAC's average broker recommendation rating improved by 0.25.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CVAC as an investment opportunity.
- In terms of how CUREVAC NV fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1897.41% of that group.
- In the context of all US stocks, CUREVAC NV's number of analysts covering the stock is higher than 195.79% of them.
- CVAC has a lower variance in analysts' estimates than -1482.06% of stocks in the large market cap category.
- In the context of stocks in the large market cap category, CUREVAC NV's average analyst price target is higher than 329.02% of them.
Stocks similar to CUREVAC NV in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MRVI, ABCL, and RVMD.
View All Top Stocks by Price Target
Is CVAC a Buy, Hold or Sell? See the POWR Ratings now!